Skip to main content
NCBI home page
Journal of Virology logoLink to Journal of Virology
. 1990 Feb;64(2):664–671. doi: 10.1128/jvi.64.2.664-671.1990

Very high frequency of reversion to guanidine resistance in clonal pools of guanidine-dependent type 1 poliovirus.

J C de la Torre 1, E Wimmer 1, J J Holland 1
PMCID: PMC249158  PMID: 2153232

Abstract

We have carefully examined the frequency of guanidine-resistant revertants in six different clonal pools of guanidine-dependent mutants of type 1 poliovirus. The mutation frequency was (6.5 +/- 6.3) x 10(-4) (with all amino acid substitutions occurring at position 227). The minimal corrected base substitution frequency per single nucleotide site in the codon for amino acid 227 was (2.1 +/- 1.9) x 10(-4).

Full text

PDF
664

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson-Sillman K., Bartal S., Tershak D. R. Guanidine-resistant poliovirus mutants produce modified 37-kilodalton proteins. J Virol. 1984 Jun;50(3):922–928. doi: 10.1128/jvi.50.3.922-928.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Batschelet E., Domingo E., Weissmann C. The proportion of revertant and mutant phage in a growing population, as a function of mutation and growth rate. Gene. 1976;1(1):27–32. doi: 10.1016/0378-1119(76)90004-4. [DOI] [PubMed] [Google Scholar]
  3. Blondel B., Crainic R., Fichot O., Dufraisse G., Candrea A., Diamond D., Girard M., Horaud F. Mutations conferring resistance to neutralization with monoclonal antibodies in type 1 poliovirus can be located outside or inside the antibody-binding site. J Virol. 1986 Jan;57(1):81–90. doi: 10.1128/jvi.57.1.81-90.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Buonagurio D. A., Nakada S., Fitch W. M., Palese P. Epidemiology of influenza C virus in man: multiple evolutionary lineages and low rate of change. Virology. 1986 Aug;153(1):12–21. doi: 10.1016/0042-6822(86)90003-6. [DOI] [PubMed] [Google Scholar]
  5. CROWTHER D., MELNICK J. L. Studies of the inhibitory action of guanidine on poliovirus multiplication in cell cultures. Virology. 1961 Sep;15:65–74. doi: 10.1016/0042-6822(61)90078-2. [DOI] [PubMed] [Google Scholar]
  6. Caliguiri L. A., Tamm I. Action of guanidine on the replication of poliovirus RNA. Virology. 1968 Jul;35(3):408–417. doi: 10.1016/0042-6822(68)90219-5. [DOI] [PubMed] [Google Scholar]
  7. Caliguiri L. A., Tamm I. The role of cytoplasmic membranes in poliovirus biosynthesis. Virology. 1970 Sep;42(1):100–111. doi: 10.1016/0042-6822(70)90242-4. [DOI] [PubMed] [Google Scholar]
  8. DeBorde D. C., Naeve C. W., Herlocher M. L., Maassab H. F. Resolution of a common RNA sequencing ambiguity by terminal deoxynucleotidyl transferase. Anal Biochem. 1986 Sep;157(2):275–282. doi: 10.1016/0003-2697(86)90626-3. [DOI] [PubMed] [Google Scholar]
  9. Diamond D. C., Jameson B. A., Bonin J., Kohara M., Abe S., Itoh H., Komatsu T., Arita M., Kuge S., Nomoto A. Antigenic variation and resistance to neutralization in poliovirus type 1. Science. 1985 Sep 13;229(4718):1090–1093. doi: 10.1126/science.2412292. [DOI] [PubMed] [Google Scholar]
  10. Domingo E., Martínez-Salas E., Sobrino F., de la Torre J. C., Portela A., Ortín J., López-Galindez C., Pérez-Breña P., Villanueva N., Nájera R. The quasispecies (extremely heterogeneous) nature of viral RNA genome populations: biological relevance--a review. Gene. 1985;40(1):1–8. doi: 10.1016/0378-1119(85)90017-4. [DOI] [PubMed] [Google Scholar]
  11. Domingo E. RNA virus evolution and the control of viral disease. Prog Drug Res. 1989;33:93–133. doi: 10.1007/978-3-0348-9146-2_5. [DOI] [PubMed] [Google Scholar]
  12. Domingo E., Sabo D., Taniguchi T., Weissmann C. Nucleotide sequence heterogeneity of an RNA phage population. Cell. 1978 Apr;13(4):735–744. doi: 10.1016/0092-8674(78)90223-4. [DOI] [PubMed] [Google Scholar]
  13. Dougherty J. P., Temin H. M. Determination of the rate of base-pair substitution and insertion mutations in retrovirus replication. J Virol. 1988 Aug;62(8):2817–2822. doi: 10.1128/jvi.62.8.2817-2822.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Durbin R. K., Stollar V. Sequence analysis of the E2 gene of a hyperglycosylated, host restricted mutant of Sindbis virus and estimation of mutation rate from frequency of revertants. Virology. 1986 Oct 15;154(1):135–143. doi: 10.1016/0042-6822(86)90436-8. [DOI] [PubMed] [Google Scholar]
  15. EGGERS H. J., TAMM I. COXSACKIE A9 VIRUS: MUTATION FROM DRUG DEPENDENCE TO DRUG INDEPENDENCE. Science. 1965 Apr 2;148(3666):97–98. doi: 10.1126/science.148.3666.97. [DOI] [PubMed] [Google Scholar]
  16. Emini E. A., Kao S. Y., Lewis A. J., Crainic R., Wimmer E. Functional basis of poliovirus neutralization determined with monospecific neutralizing antibodies. J Virol. 1983 May;46(2):466–474. doi: 10.1128/jvi.46.2.466-474.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Emini E. A., Leibowitz J., Diamond D. C., Bonin J., Wimmer E. Recombinants of Mahoney and Sabin strain poliovirus type 1: analysis of in vitro phenotypic markers and evidence that resistance to guanidine maps in the nonstructural proteins. Virology. 1984 Aug;137(1):74–85. doi: 10.1016/0042-6822(84)90010-2. [DOI] [PubMed] [Google Scholar]
  18. Evans D. M., Minor P. D., Schild G. S., Almond J. W. Critical role of an eight-amino acid sequence of VP1 in neutralization of poliovirus type 3. Nature. 1983 Aug 4;304(5925):459–462. doi: 10.1038/304459a0. [DOI] [PubMed] [Google Scholar]
  19. Gebauer F., de la Torre J. C., Gomes I., Mateu M. G., Barahona H., Tiraboschi B., Bergmann I., de Mello P. A., Domingo E. Rapid selection of genetic and antigenic variants of foot-and-mouth disease virus during persistence in cattle. J Virol. 1988 Jun;62(6):2041–2049. doi: 10.1128/jvi.62.6.2041-2049.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Holland J., Spindler K., Horodyski F., Grabau E., Nichol S., VandePol S. Rapid evolution of RNA genomes. Science. 1982 Mar 26;215(4540):1577–1585. doi: 10.1126/science.7041255. [DOI] [PubMed] [Google Scholar]
  21. Huang A. S., Balitmore D. Initiation of polyribosome formation in poliovirus-infected HeLa cells. J Mol Biol. 1970 Feb 14;47(3):275–291. doi: 10.1016/0022-2836(70)90302-5. [DOI] [PubMed] [Google Scholar]
  22. Huovilainen A., Hovi T., Kinnunen L., Takkinen K., Ferguson M., Minor P. Evolution of poliovirus during an outbreak: sequential type 3 poliovirus isolates from several persons show shifts of neutralization determinants. J Gen Virol. 1987 May;68(Pt 5):1373–1378. doi: 10.1099/0022-1317-68-5-1373. [DOI] [PubMed] [Google Scholar]
  23. Kew O. M., Nottay B. K., Hatch M. H., Nakano J. H., Obijeski J. F. Multiple genetic changes can occur in the oral poliovaccines upon replication in humans. J Gen Virol. 1981 Oct;56(Pt 2):337–347. doi: 10.1099/0022-1317-56-2-337. [DOI] [PubMed] [Google Scholar]
  24. LODDO B., FERRARI W., BROTZU G., SPANEDDA A. In vitro inhibition of infectivity of polio viruses by guanidine. Nature. 1962 Jan 6;193:97–98. doi: 10.1038/193097a0. [DOI] [PubMed] [Google Scholar]
  25. Leider J. M., Palese P., Smith F. I. Determination of the mutation rate of a retrovirus. J Virol. 1988 Sep;62(9):3084–3091. doi: 10.1128/jvi.62.9.3084-3091.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Lubeck M. D., Schulman J. L., Palese P. Antigenic variants of influenza viruses: marked differences in the frequencies of variants selected with different monoclonal antibodies. Virology. 1980 Apr 30;102(2):458–462. doi: 10.1016/0042-6822(80)90114-2. [DOI] [PubMed] [Google Scholar]
  27. Minor P. D., John A., Ferguson M., Icenogle J. P. Antigenic and molecular evolution of the vaccine strain of type 3 poliovirus during the period of excretion by a primary vaccinee. J Gen Virol. 1986 Apr;67(Pt 4):693–706. doi: 10.1099/0022-1317-67-4-693. [DOI] [PubMed] [Google Scholar]
  28. Minor P. D., Schild G. C., Bootman J., Evans D. M., Ferguson M., Reeve P., Spitz M., Stanway G., Cann A. J., Hauptmann R. Location and primary structure of a major antigenic site for poliovirus neutralization. Nature. 1983 Feb 24;301(5902):674–679. doi: 10.1038/301674a0. [DOI] [PubMed] [Google Scholar]
  29. Nichol S. T., Rowe J. E., Fitch W. M. Glycoprotein evolution of vesicular stomatitis virus New Jersey. Virology. 1989 Feb;168(2):281–291. doi: 10.1016/0042-6822(89)90268-7. [DOI] [PubMed] [Google Scholar]
  30. Noble J., Levintow L. Dynamics of poliovirus-specific RNA synthesis and the effects of inhibitors of virus replication. Virology. 1970 Mar;40(3):634–642. doi: 10.1016/0042-6822(70)90208-4. [DOI] [PubMed] [Google Scholar]
  31. Parvin J. D., Moscona A., Pan W. T., Leider J. M., Palese P. Measurement of the mutation rates of animal viruses: influenza A virus and poliovirus type 1. J Virol. 1986 Aug;59(2):377–383. doi: 10.1128/jvi.59.2.377-383.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Penman S., Summers D. Effects on host cell metabolism following synchronous infection with poliovirus. Virology. 1965 Dec;27(4):614–620. doi: 10.1016/0042-6822(65)90187-x. [DOI] [PubMed] [Google Scholar]
  33. Pincus S. E., Diamond D. C., Emini E. A., Wimmer E. Guanidine-selected mutants of poliovirus: mapping of point mutations to polypeptide 2C. J Virol. 1986 Feb;57(2):638–646. doi: 10.1128/jvi.57.2.638-646.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Pincus S. E., Rohl H., Wimmer E. Guanidine-dependent mutants of poliovirus: identification of three classes with different growth requirements. Virology. 1987 Mar;157(1):83–88. doi: 10.1016/0042-6822(87)90316-3. [DOI] [PubMed] [Google Scholar]
  35. Pincus S. E., Wimmer E. Production of guanidine-resistant and -dependent poliovirus mutants from cloned cDNA: mutations in polypeptide 2C are directly responsible for altered guanidine sensitivity. J Virol. 1986 Nov;60(2):793–796. doi: 10.1128/jvi.60.2.793-796.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Popescu M., Lehmann-Grube F. Diversity of lymphocytic choriomeningitis virus: variation due to replication of the virus in the mouse. J Gen Virol. 1976 Jan;30(1):113–122. doi: 10.1099/0022-1317-30-1-113. [DOI] [PubMed] [Google Scholar]
  37. RIGHTSEL W. A., DICE J. R., McALPINE R. J., TIMM E. A., McLEAN I. W., Jr, DIXON G. J., SCHABEL F. M., Jr Antiviral effect of guanidine. Science. 1961 Aug 25;134(3478):558–559. doi: 10.1126/science.134.3478.558. [DOI] [PubMed] [Google Scholar]
  38. Sanger F., Nicklen S., Coulson A. R. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5463–5467. doi: 10.1073/pnas.74.12.5463. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Saunders K., King A. M. Guanidine-resistant mutants of aphthovirus induce the synthesis of an altered nonstructural polypeptide, P34. J Virol. 1982 May;42(2):389–394. doi: 10.1128/jvi.42.2.389-394.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Sedivy J. M., Capone J. P., RajBhandary U. L., Sharp P. A. An inducible mammalian amber suppressor: propagation of a poliovirus mutant. Cell. 1987 Jul 31;50(3):379–389. doi: 10.1016/0092-8674(87)90492-2. [DOI] [PubMed] [Google Scholar]
  41. Smith D. B., Inglis S. C. The mutation rate and variability of eukaryotic viruses: an analytical review. J Gen Virol. 1987 Nov;68(Pt 11):2729–2740. doi: 10.1099/0022-1317-68-11-2729. [DOI] [PubMed] [Google Scholar]
  42. Sobrino F., Dávila M., Ortín J., Domingo E. Multiple genetic variants arise in the course of replication of foot-and-mouth disease virus in cell culture. Virology. 1983 Jul 30;128(2):310–318. doi: 10.1016/0042-6822(83)90258-1. [DOI] [PubMed] [Google Scholar]
  43. Spindler K. R., Horodyski F. M., Holland J. J. High multiplicities of infection favor rapid and random evolution of vesicular stomatitis virus. Virology. 1982 May;119(1):96–108. doi: 10.1016/0042-6822(82)90068-x. [DOI] [PubMed] [Google Scholar]
  44. Stec D. S., Waddell A., Schmaljohn C. S., Cole G. A., Schmaljohn A. L. Antibody-selected variation and reversion in Sindbis virus neutralization epitopes. J Virol. 1986 Mar;57(3):715–720. doi: 10.1128/jvi.57.3.715-720.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Steinhauer D. A., Holland J. J. Rapid evolution of RNA viruses. Annu Rev Microbiol. 1987;41:409–433. doi: 10.1146/annurev.mi.41.100187.002205. [DOI] [PubMed] [Google Scholar]
  46. Steinhauer D. A., de la Torre J. C., Holland J. J. High nucleotide substitution error frequencies in clonal pools of vesicular stomatitis virus. J Virol. 1989 May;63(5):2063–2071. doi: 10.1128/jvi.63.5.2063-2071.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Steinhauer D. A., de la Torre J. C., Meier E., Holland J. J. Extreme heterogeneity in populations of vesicular stomatitis virus. J Virol. 1989 May;63(5):2072–2080. doi: 10.1128/jvi.63.5.2072-2080.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Tershak D. R. Inhibition of poliovirus polymerase by guanidine in vitro. J Virol. 1982 Jan;41(1):313–318. doi: 10.1128/jvi.41.1.313-318.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Ward C. D., Stokes M. A., Flanegan J. B. Direct measurement of the poliovirus RNA polymerase error frequency in vitro. J Virol. 1988 Feb;62(2):558–562. doi: 10.1128/jvi.62.2.558-562.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. White B. T., McGeoch D. J. Isolation and characterization of conditional lethal amber nonsense mutants of vesicular stomatitis virus. J Gen Virol. 1987 Dec;68(Pt 12):3033–3044. doi: 10.1099/0022-1317-68-12-3033. [DOI] [PubMed] [Google Scholar]
  51. Yin F. H. Involvement of viral procapsid in the RNA synthesis and maturation of poliovirus. Virology. 1977 Oct 15;82(2):299–307. doi: 10.1016/0042-6822(77)90005-8. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES